Jason Haas, Director, on June 12, 2026, sold 6,461 shares in Ligand Pharmaceuticals (LGND) for $1,651,320. Following the Form 4 filing with the SEC, Haas has control over a total of 4,981 common shares of the company, with 4,981 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/886163/000200101126000104/xslF345X05/edgardoc.xml
Shiv Verma, Chief Financial Officer, on June 15, 2026, sold 3,984 shares in Robinhood Markets (HOOD) for $393,779. Following the Form 4 filing with the SEC, Verma has control over a total of 59,927 Class A common shares of the company, with 59,927 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1783879/000210858926000016/xslF345X05/wk-form4_1781559683.xml
Joshua S Boger, 10% Owner, Director, on June 11, 2026, executed a purchase for 955,414 shares in Cervomed (CRVO) for $3,000,000. Following the Form 4 filing with the SEC, Boger has control over a total of 2,012,682 common shares of the company, with 216,817 shares held directly and 1,795,865 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/xslF345X05/rdgdoc.xml
Jennifer H. Broyles, Executive Vice President, Global Brands President, on June 12, 2026, sold 4,000 shares in Kontoor Brands (KTB) for $324,080. Following the Form 4 filing with the SEC, Broyles has control over a total of 46,912 common shares of the company, with 40,261 shares held directly and 6,651 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1760965/000089706926001397/xslF345X05/form4.xml